STOCK TITAN
  1. Home
  2. GWPH

GW Pharma (GWPH) Stock Price, News & Analysis

GWPH NASDAQ
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
11 253 sessions, May 4, 2020 to May 4, 2021
Largest daily move
+44.5% close of February 3, 2021
1-year change
+110% closing prices, May 4, 2020 to May 4, 2021
1-month change
+0.8% closing prices, April 1, 2021 to May 4, 2021

Company Description

GWPH gained 110.0% in the 12 months to May 4, 2021. The last closing price was $218.96.

This page collects what Stock Titan holds for GWPH, including price data and latest news.

Stock Performance

Chart
$218.96
No recent trading
Last close: May 4, 2021
+110%
1 year to May 4, 2021
-
Market Cap
-
Shares outstanding

GW Pharma (GWPH) closed at $218.96 on May 4, 2021. In the 12 months to May 4, 2021, the price gained 110.0%.

See what a $1,000 investment in GWPH would be worth today

Average down calculator for GWPH

GWPH Metrics & Rankings

May 2021
+0.0%
—
2021
+89.7%
—

Price returns through May 4, 2021. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

View All
—

IDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice President, General Counsel

management
—

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc

acquisition
+0.09%

GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for Enterprise in Innovation

-0.03%

GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals

acquisition
-0.06%

GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex

+0.11%

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting

conferences
-0.28%

GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated with Tuberous Sclerosis Complex

-0.20%

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2020 Financial Results and Operational Progress

earnings
+44.53%

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

acquisition
-2.19%

GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones

GW Pharma has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include management, acquisition, conferences, earnings. View all GWPH news →

SEC Filings

No SEC filings available for GWPH.

Frequently Asked Questions

GW Pharma (GWPH) has no recent trading. Its last close was $218.96 on May 4, 2021.